Physician profile
Ryan Casey Mcgowan
NPI 1417536129
$1,507.75
in general payments reported to CMS, 2019-2025
9 companies · $1,508 in 2025
The $1,508 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,437 · Travel and Lodging: $70.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,437.19 |
| Travel and Lodging | $70.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,011.77 | 2025 | Prostep Mica, Inbone, Pangea |
| Integra Lifesciences Corporation | $162.43 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Urgo Medical North America, LLC | $142.57 | 2025 | Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| United Orthopedics LLC | $61.46 | 2025 | |
| Averitas Pharma INC. | $35.19 | 2025 | Qutenza |
| Smith+Nephew, INC. | $28.80 | 2025 | Grafix Pl, Grafix, Stravix Pl |
| Dynasplint Systems INC. | $24.00 | 2025 | Dynasplint |
| Organogenesis INC. | $23.99 | 2025 | Apligraf |
| Tactile Systems Technology INC | $17.54 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mcgowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.